158 related articles for article (PubMed ID: 17533931)
1. [3/3 Steroidal or glucocorticoid anti-inflammatories].
Grangeasse L; Limat S; Woronoff-Lemsi MC
Soins; 2007 Apr; (714):59-61. PubMed ID: 17533931
[No Abstract] [Full Text] [Related]
2. [Prescription and surveillance of steroidal and non-steroidal anti-inflammatory drugs].
Berenbaum F
Rev Prat; 2004 Apr; 54(7):781-9. PubMed ID: 15253298
[No Abstract] [Full Text] [Related]
3. Prescription drugs uses and effects. Corticosteroids.
Jordan S; Griffiths H
Nurs Stand; 2004 Mar 17-23; 18(27):2p.. PubMed ID: 15061025
[No Abstract] [Full Text] [Related]
4. Therapeutic issues in oral glucocorticoid use.
Bello CE; Garrett SD
Lippincotts Prim Care Pract; 1999; 3(3):333-41; quiz 342-4. PubMed ID: 10711134
[TBL] [Abstract][Full Text] [Related]
5. Topical corticosteroids: a review of properties and principles in therapeutic use.
Chaffman MO
Nurse Pract Forum; 1999 Jun; 10(2):95-105. PubMed ID: 10542586
[TBL] [Abstract][Full Text] [Related]
6. Methylprednisolone.
Nurs Times; 2005 Oct 11-17; 101(41):31. PubMed ID: 16255104
[No Abstract] [Full Text] [Related]
7. Therapeutic implications of non-genomic glucocorticoid activity.
Lipworth BJ
Lancet; 2000 Jul; 356(9224):87-9. PubMed ID: 10963239
[No Abstract] [Full Text] [Related]
8. Update of the clinical issues regarding methadone (Dolophine) therapy in pain management.
Linderbeck LR
AACN Adv Crit Care; 2008; 19(3):253-7. PubMed ID: 18670197
[No Abstract] [Full Text] [Related]
9. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists.
Stahn C; Löwenberg M; Hommes DW; Buttgereit F
Mol Cell Endocrinol; 2007 Sep; 275(1-2):71-8. PubMed ID: 17630118
[TBL] [Abstract][Full Text] [Related]
10. [What happens in the body with glucocorticoids? Pharmacokinetics and pharmacodynamics].
Högger P
Pharm Unserer Zeit; 2003; 32(4):296-301. PubMed ID: 12899066
[No Abstract] [Full Text] [Related]
11. [Interesting practical facts on the pharmacology of non-steroidal antirheumatic agents].
Fenner H
Wien Med Wochenschr; 1982 Dec; 132(23-24):586-8. PubMed ID: 6819722
[No Abstract] [Full Text] [Related]
12. Genomic and nongenomic effects of glucocorticoids.
Stahn C; Buttgereit F
Nat Clin Pract Rheumatol; 2008 Oct; 4(10):525-33. PubMed ID: 18762788
[TBL] [Abstract][Full Text] [Related]
13. Current issues of basic and clinical glucocorticoid research.
Buttgereit F
Clin Exp Rheumatol; 2003; 21(2):145-7. PubMed ID: 12747266
[No Abstract] [Full Text] [Related]
14. Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids.
Cuzzocrea S; Bruscoli S; Mazzon E; Crisafulli C; Donato V; Di Paola R; Velardi E; Esposito E; Nocentini G; Riccardi C
Mol Pharmacol; 2008 Feb; 73(2):323-37. PubMed ID: 17984196
[TBL] [Abstract][Full Text] [Related]
15. [Drug profile. Prednisolone].
Hinz B; Schröder H
Dtsch Med Wochenschr; 1998 Jul; 123(31-32):943-4. PubMed ID: 9721570
[No Abstract] [Full Text] [Related]
16. [The oral corticoids].
Portet L
Soins; 1997 Apr; (614):45-6. PubMed ID: 9216420
[No Abstract] [Full Text] [Related]
17. [1/3 Non-steroidal anti-inflammatory drugs].
Medjoub M; Limat S
Soins; 2007; (712):59-60. PubMed ID: 17333712
[No Abstract] [Full Text] [Related]
18. Repeat survey of current practice regarding corticosteroid prophylaxis for patients at increased risk for adverse reaction to intravascular contrast agents.
Morcos SK
Clin Radiol; 2005 Jun; 60(6):728. PubMed ID: 16038703
[No Abstract] [Full Text] [Related]
19. Corticosteroid therapy, nonendocrine disease, and corticosteroid withdrawal.
Magiakou MA; Chrousos GP
Curr Ther Endocrinol Metab; 1994; 5():120-4. PubMed ID: 7704695
[No Abstract] [Full Text] [Related]
20. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
Spijker AJ
Ned Tijdschr Geneeskd; 2006 May; 150(21):1205; author reply 1205. PubMed ID: 16768287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
